Search results for "Chronic kidney disease"
ADA updates diabetes standards of care for 2023
The American Diabetes Association (ADA) has changed its recommendations on hypertension cutoffs, use of statins, and treatment of patients with diabetes and chronic kidney disease, among other topics.
https://immattersacp.org/weekly/archives/2022/12/20/1.htm
20 Dec 2022
MKSAP Quiz: Follow-up for hypertension, chronic kidney disease
A 74-year-old woman is evaluated during a follow-up visit for hypertension and slowly progressive chronic kidney disease. She reports that she feels well and has no symptoms. Following a physical exam and lab studies, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2022/12/13/3.htm
13 Dec 2022
Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes
A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/12/06/3.htm
6 Dec 2022
MKSAP Quiz: Follow-up for diabetes, hyperlipidemia, hypertension
A 68-year-old man is evaluated during a routine follow-up visit. Medical history is significant for type 2 diabetes mellitus, hyperlipidemia, hypertension, and aortofemoral bypass surgery 2 years ago. Following a physical exam, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2022/11/15/3.htm
15 Nov 2022
Stopping renin-angiotensin system inhibitors in advanced CKD did not appear to affect eGFR
A randomized open-label trial in the United Kingdom found that withdrawal of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with advanced chronic kidney disease (CKD) did not affect estimated glomerular filtration rate (eGFR).
https://immattersacp.org/weekly/archives/2022/11/08/2.htm
8 Nov 2022
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022
New trials provide data to improve medication management in hypertension
A U.K. study compared morning versus evening dosing of antihypertensive drugs, a U.S. study looked at optimal dosing in patients with proteinuria, and a trial in Spain tested self-titration in patients with poorly controlled hypertension.
https://immattersacp.org/weekly/archives/2022/10/18/6.htm
18 Oct 2022
Diltiazem may increase bleeding risk when coadministered with DOACs in afib
A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://immattersacp.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022
Post-COVID-19 clinic director offers tips on lingering symptoms
The first step to treating patients with postacute sequelae of SARS-CoV-2 (PASC) is simple, one expert said: Believe them.
https://immattersacp.org/archives/2022/06/post-covid-19-clinic-director-offers-tips-on-lingering-symptoms.htm
1 Jun 2022
Factoring drug costs into diabetes decisions
A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://immattersacp.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022